A Real-world Study of Inetetamab for First-line Treatment of MBC

NCT05980208 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Real-world Study

Interventions

DRUG: Inetetamab

Sponsor

Hunan Cancer Hospital

Collaborators

[object Object]